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Raman spectroscopic detection of 
high-grade cervical cytology: Using 
morphologically normal appearing 
cells
Shiyamala Duraipandian1,2,5, Damien Traynor1,2, Padraig Kearney2, Cara Martin3,4, 
John J. O’Leary3,4 & Fiona M. Lyng  1,2
This study aims to detect high grade squamous intraepithelial cells (HSIL) by investigating HSIL 
associated biochemical changes in morphologically normal appearing intermediate and superficial cells 
using Raman spectroscopy. Raman spectra (n = 755) were measured from intermediate and superficial 
cells from negative cytology ThinPrep specimens (n = 18) and from morphologically normal appearing 
intermediate and superficial cells from HSIL cytology ThinPrep specimens (n = 17). The Raman data was 
subjected to multivariate algorithms including the standard principal component analysis (PCA)-linear 
discriminant analysis (LDA) and partial least squares discriminant analysis (PLS-DA) together with 
random subsets cross-validation for discriminating negative cytology from HSIL. The PCA-LDA method 
yielded sensitivities of 74.9%, 72.8%, and 75.6% and specificities of 89.9%, 81.9%, and 84.5%, for 
HSIL diagnosis based on the dataset obtained from intermediate, superficial and mixed intermediate/
superficial cells, respectively. The PLS-DA method provided improved sensitivities of 95.5%, 95.2% 
and 96.1% and specificities of 92.7%, 94.7% and 93.5% compared to the PCA-LDA method. The results 
demonstrate that the biochemical signatures of morphologically normal appearing cells can be used to 
discriminate between negative and HSIL cytology. In addition, it was found that mixed intermediate 
and superficial cells could be used for HSIL diagnosis as the biochemical differences between negative 
and HSIL cytology were greater than the biochemical differences between intermediate and superficial 
cell types.
Cervical cancer is the 4th most common cause of cancer death in women worldwide and the 7th most common 
cause of cancer death in females in Europe1. In 2012, more than 265,000 deaths were estimated from cervical 
cancer worldwide1. Persistent infection with human papilloma virus (HPV) causes almost all cervical cancer and 
precancer. The Papanicolaou (Pap) test is the routine test for identifying any abnormality in the cervix. In the Pap 
test, the cells are scraped from the cervix and examined for the presence of precancerous and cancerous changes. 
The Pap test results have the following categories: negative for neoplastic cellular changes, atypical squamous 
cells of undetermined significance, low-grade squamous intraepithelial lesions (LSIL) and high-grade squamous 
intraepithelial lesion (HSIL)2. The identification of cancer and precancer using this standard cytology method 
depends on the visual assessment of characteristics of individual cells3. This can cause intra- and inter-observer 
disagreements and makes this standard cytology procedure highly subjective with very low sensitivity (68.5%)4. 
Hence, there is a high possibility for missing the premalignant lesions of the cervix. Currently, there is an unmet 
clinical need to develop new methods to objectively identify patients who are at high risk of developing cervical 
cancer.
Recently, Raman spectroscopy has received huge interest due to its capability to probe the fingerprint of bio-
molecules and their changes associated with cancer and its precursors3,5–9. Numerous ex vivo and in vivo studies 
have explored the potential of Raman spectroscopy for cervical cancer and precancer detection in tissues and cell 
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lines6,7,9–13. Relatively few studies have focused on cervical cytology9,13–16. Using cell pellets rather than single cells, 
Vargis et al.15 showed that HPV-positive and -negative cytology samples could be classified with an accuracy of 
98.5% and Rubina et al.14 showed that normal and cervical cancer cytology samples could be classified with an 
accuracy of ~80%. Previous work from our group has developed a protocol for processing liquid-based cytology 
(ThinPrep) cervical specimens for Raman spectroscopic analysis16. High quality Raman spectra were successfully 
recorded from single exfoliated cells and >90% sensitivity and specificity was achieved to discriminate the cells 
with negative cytology from the cells with HSIL cytology13,17. In these cervical cytology samples, the majority 
of the cells are from uppermost layers of cervical epithelium (i.e., intermediate and superficial layers), while 
parabasal cells (from the basal layer) are more abundant in atrophic smears from menopausal women. A recent 
study from our group has shown that each cell type (superficial, intermediate, parabasal) has its own unique 
Raman signatures which can be discriminated from the Raman signatures of HSIL cells13. As cervical precancer 
progresses from basal to superficial layer, the morphological features/changes associated with HSIL may not 
be apparent in the uppermost intermediate and superficial layers. Furthermore, Raman spectroscopy requires 
unstained slides for investigation of cells and tissues. Consequently, it can be extremely difficult to find the rare 
HSIL cells (morphologically abnormal cells) in these unstained ThinPrep slides. In an early Fourier-transform 
infrared (FTIR) spectroscopy study, Cohenford and Rigas showed that the spectra of morphologically normal 
cells from women with dysplasia or cancer exhibit extensive IR spectroscopic changes18. This finding was later 
confirmed by Schubert et al. who showed that FTIR spectral changes in cytologically normal cells are most likely 
due to HPV infection19. In the present study, the initial aim was to determine if it was possible to detect HSIL 
related changes in the cervix by analysing the morphologically normal appearing superficial and intermediate 
epithelial cells in HSIL cytology samples using Raman spectroscopy. To our knowledge, this has not been shown 
previously. A further aim was to determine the ability to discriminate between the negative and HSIL cytology 
cases using intermediate cells, superficial cells and a mixed population of intermediate and superficial cells.
Materials and Methods
Sample collection and processing. Negative and HSIL ThinPrep cytology specimens were collected from 
the colposcopy clinic, Coombe Women and Infants University Hospital (CWIUH), Dublin, Ireland. This study 
was approved by and carried out in accordance with the Research Ethics Committee at CWIUH. After obtaining 
informed consent, the specimens were collected according to cytology standard operating procedures (SOP) 
and then processed via ThinPrepTM method16. The cells from the cervix were scraped using a cytobrush and then 
rinsed in the specimen vial containing a methanol based fixative i.e., PreservCyt transport medium (ThinPrep 
Pap Test, Screenlink, Dublin). Although fixation and other processing steps have been shown to result in bio-
chemical changes in cells and tissues20, it was not possible to change this procedure as these were clinical sam-
ples collected according to the standard cytology laboratory workflow. The labelled ThinPrep sample vials were 
then sent to the cytology laboratory equipped with a ThinPrep processor. The ThinPrep processor (Hologic Inc., 
Marlborough, MA) homogenizes the sample by spinning the filter (T2000), creating shear forces in the fluid that 
are strong enough to disaggregate randomly joined material, break up blood, mucus and non-diagnostic debris 
while keeping true cell clusters intact16. The cells were then collected onto the membrane of the TransCyt filter 
and further transferred onto a glass slide to create a monolayer deposit of cells (~20 mm in diameter). The slide 
was then transferred into a fixative bath of 95% ethanol automatically. In total, 35 unstained cytology samples 
on ThinPrepTM slides (18 negative and 17 HSIL) were obtained and subjected to Raman spectroscopic analysis. 
Before Raman measurement, each slide was pre-treated with hydrogen peroxide (H2O2) to remove any contam-
inating blood and debris16. Briefly, the slides were treated with a 30% solution of H2O2 at room temperature for 
3 minutes. The slides were then placed into a 70% solution of industrial methylated spirits (IMS) for 3 minutes 
followed by multiple dips into 100% IMS to remove any remaining cellular debris and H2O2. The slide was then 
air dried.
Raman instrumentation. Raman spectra were recorded using a HORIBA Jobin Yvon XploRATM sys-
tem (Villeneuve d’Ascq, France), incorporating an Olympus microscope BX41 equipped with a ×100 objec-
tive (NA = 0.9). The system consists of a 532 nm diode laser, 1200 lines/mm grating and an air-cooled CCD 
detector (024 × 256 pixels). The system was wavelength calibrated to the 520.7 cm−1 spectral line of silicon and 
also intensity-calibrated using a relative intensity correction standard (NIST 2242). In this study, a total of ~755 
Raman signals were measured from the ThinPrep specimens of 35 patients (18 negative and 17 HSIL). From 
each slide, 10 to 15 intermediate and superficial epithelial cells were randomly selected and good quality Raman 
spectra were obtained with an integration time of 30 sec and 2 accumulations to improve the signal to noise ratio. 
The laser power on the sample was ~1 mW. The images of the Raman measured cells were recorded together with 
x- and y- coordinates. After the Raman spectral acquisition, the samples were Pap stained and each recorded cell 
was re-visited using the stored x- and y- co-ordinates to verify whether the cells were from the intermediate or 
superficial layer.
Data analysis. All the recorded Raman spectra were corrected for the glass background using a linear 
least-squares method with non-negative constraints. The least-squares model was developed using the basis 
spectra obtained from pure glass slides and selected pure biochemicals (e.g., actin, collagen, RNA, DNA, etc.) 
that approximate the biochemical composition of cervical cells. The Raman dataset has also been corrected for 
the baseline and then vector normalized. The Raman data was mean-centered and then subjected to multivari-
ate algorithms including the standard principal component analysis (PCA)-linear discriminant analysis (LDA)21 
and partial least squares discriminant analysis (PLS-DA)22,23 together with random subsets cross-validation for 
discriminating negative cytology from HSIL. In this cross validation, the data are randomly split into many sub-
sets. Different test sets are selected through random selection of samples (total number of samples/number of 
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split (n = 20)) in the dataset in such a way that no single sample is in more than one test set and this procedure 
is iterated multiple times. PCA projects the data in the direction of maximum variability and retains most of the 
information in a smaller number of these projected variables. LDA further maximizes separation between the 
classes in these PCA-projected variables and minimizes the separation within a class21. Following PCA-LDA, 
PLS-DA was applied on the same dataset because PCA only involves one set of data, but PLS reduces the data by 
explaining as much variance as possible by considering the correlated relationships between the Raman spectral 
dataset and the class membership (i.e., 0 s and 1 s to represent each observation)24,25. Hence, PLS-DA considers 
diagnostically relevant variations and obtains maximum group separation by rotating the latent variables (LVs). 
The PCA-LDA was carried out using custom scripts written in MATLAB (Mathworks, Inc. Natick, MA). The 
PLS-DA analysis was performed using the PLS toolbox (Eigenvector Research, Wenatchee, WA) in the Matlab 
scripting environment.
Results and Discussion
Figure 1 shows the intermediate and the superficial cells collected from the negative and HSIL cytology spec-
imens. The intermediate and the superficial cells are indistinguishable in unstained slides (Fig. 1(a,c)). Raman 
spectra were randomly recorded from the morphologically normal looking cells from unstained negative 
and HSIL cytology slides as the Pap stain components have their own unique Raman signatures which inter-
fere with the cellular Raman spectrum. Following the Raman measurements, the x, y coordinates for each cell 
were recorded. After completing the Raman measurements, the slide was stained using the Pap stain. Using the 
recorded x, y coordinates, each cell was reviewed and assigned as intermediate or superficial based on the staining 
pattern i.e., the intermediate cells are turquoise green to blue in colour and the superficial cells are orange to pink 
in colour (Fig. 1(b,d)).
The mean normalized Raman spectra obtained from the intermediate cells (negative (n = 176), HSIL 
(n = 252), Fig. 2a) and the superficial cells (negative (n = 174), HSIL (n = 153), Fig. 2b) are shown in Fig. 2. The 
spectra were recorded in the fingerprint region (400 to 1800 cm−1) due to the presence of abundant Raman 
bands that are unique for different biomolecules that comprise cervical cells and tissue, such as proteins, glyco-
gen, lipids, DNA, etc. The Raman spectra obtained from the intermediate cells (maximum standard deviation 
(SD) = ±0.0049) and superficial cells (maximum SD = ±0.0056) are quite consistent. A larger spectral varia-
bility was reported previously for spectra recorded from the superficial layer in cervical tissue sections due to 
the variation in the glycogen content associated with women’s age, hormonal levels and menstrual cycle26. Our 
previous study on cervical exfoliated cells also showed a higher spectral variability in the spectra recorded from 
the cytoplasm due to glycogen content13. In the present study, the consistency observed among the Raman spec-
tra of superficial cells is probably due to the reason that the Raman signals were measured from the cell nucleus. 
The measured Raman spectra from intermediate and superficial cell types contain complex, overlapped spectral 
signatures in relation to the tissue biochemistry. Raman peaks can be observed in the vicinity of 482 cm−1 (gly-
cogen), 621 and 644 cm−1 (proteins), 784 cm−1 (DNA), 828 cm−1 (DNA/RNA), 855 and 936 cm−1 (glycogen and 
Figure 1. (a) Unstained and (b) Pap stained image of negative cytology specimen, X10. (c) Unstained and 
(d) Pap stained image of high-grade squamous intraepithelial lesion (HSIL) cytology specimen, X10. In (b,d), 
superficial cells are orange to pink in colour and intermediate cells are turquoise green to blue in colour.
www.nature.com/scientificreports/
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proteins), 957 cm−1 (DNA), 1004 cm−1 (phenylalanine), 1092 cm−1 (DNA phosphate backbone), 1127 cm−1 (pro-
teins), 1176 cm−1 (cytosine/guanine), 1245 cm−1 (amide III), 1338 cm−1 (proteins and nucleic acids), 1450 cm−1 
(proteins, lipids), 1578 cm−1 (nucleic acids), and 1669 cm−1 (amide I)3,6,16,17,27–29. The main Raman peaks and 
their tentative assignments are summarized in Table 1. The main differences between the Raman spectra acquired 
from the intermediate cells (Fig. 3a) or superficial cells (Fig. 3b) from negative and HSIL cytology specimens 
were observed at 482, 621, 728, 828, 855, 936, 957, 1092, 1176, 1210, 1422, 1450, 1578, 1610, 1619, and 1669 cm−1 
(unpaired two-sided Student’s t-test, p < 0.001). These bands are mainly related to DNA, proteins and glycogen. 
It is very interesting that many of the features are similar for the intermediate and superficial cells. This can be 
explained from the fact that the intermediate layer is the transitional layer between the immature cells of the 
basal/parabasal layer and the mature cells of the superficial layer30. Hence, the intermediate and superficial layers 
are expected to have similar molecular composition such as glycogen, DNA, proteins, etc. This is consistent with 
our previous study which showed clustering of stroma, basal/parabasal, and superficial/intermediate layers char-
acterised by the spectral features of collagen, DNA bases, and glycogen, respectively31.
As the visual differences between the Raman spectra from negative and HSIL cytology specimens are sub-
tle, multivariate analysis, PLS-DA, was utilized to enhance the spectral differences. The PLS-DA models were 
developed from the intermediate, superficial, mixed intermediate/superficial dataset. The number of LVs or PLS 
Figure 2. (a) Mean Raman spectra ±1 standard deviation (SD) acquired from the intermediate cells of negative 
cytology ThinPrep specimens (n = 18) and morphologically normal appearing intermediate cells of high-grade 
squamous intraepithelial lesion (HSIL) ThinPrep specimens (n = 17). (b) Mean Raman spectra ±1 SD acquired 
from the superficial cells of negative cytology specimens (n = 18) and morphologically normal appearing 
superficial cells of HSIL cytology ThinPrep specimens (n = 17).
Wavenumber (cm−1) Raman Peak Assignments
482 Glycogen
621 C-C twisting mode of Phenylalanine (proteins)
644 C-C twisting mode of Tyrosine and Phenylalanine
784 Uracil, Thymine, Cytosine (ring breathing modes in the DNA/RNA)
828 PO2 stretching in DNA, Tyrosine
855 Ring breathing in Tyrosine and Proline (proteins)
936 C-C stretching mode of Proline and Valine
957 C-C and C-N stretch PO32− stretch (DNA)
1004 C-C aromatic ring stretching in Phenylalanine
1092 Symmetric PO2− stretching vibration of the DNA
1127 C-N stretching in proteins
1176 C-H in plane bending mode of Tryptophan & Phenylalanine; Cytosine, Guanine
1245 Amide III (of collagen)
1338 CH2/CH3 wagging & twisting mode in collagen, nucleic acid & tryptophan
1450 CH (CH2) bending mode in proteins and lipids
1578 Adenine, Guanine (DNA/RNA); C=C bending mode of Phenylalanine
1669 Amide I (C=O stretching, C-N stretching and N-H bending, proteins)
Table 1. Tentative peak assignments for cell Raman spectra displayed in Fig. 2.
www.nature.com/scientificreports/
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components (4LVs, 3LVs and 6LVs, Fig. 4) corresponding to minimum cross-validation error were utilized to 
develop the models for intermediate, superficial and mixed intermediate/superficial datasets, respectively. The 
LVs (Fig. 4b) for the superficial dataset accounted for 57.2% and 76.5% of the total Raman spectral variations in 
the X and Y directions and predominantly provided information about DNA and proteins (620, 640, 1004, 1338, 
1450, 1578, and 1669 cm−1), glycogen and proteins (482, 855, and 936 cm−1). Similarly, the LVs (50.7% variation 
in X direction and 72.3% variation in Y direction, Fig. 4a) corresponding to the intermediate dataset mainly 
showed changes in glycogen, DNA and protein features (482, 620, 640, 780, 855, 1004, 1210, 1450, 1578, and 
1669 cm−1). Combining the intermediate and superficial dataset, the LVs (67.8% and 76.0% variations in X and Y 
direction, Fig. 4c) extracted information around the Raman peaks 780, and 1578 cm−1 (DNA), and 482, 620, 640, 
855, 936, 1004, 1338, 1450, and 1669 cm−1 (glycogen and proteins). From the above results, it is clear that both 
cell types either utilized separately or in combination provide almost similar diagnostic information associated 
with HSIL diagnosis. The LV scores scatter plot (Fig. 5) obtained from the mixed intermediate/superficial dataset 
visually shows that the scores of intermediate and superficial cells from negative cytology specimens are over-
lapped due to minimal variability between the two cell types. Similarly, the scores of intermediate and superficial 
cells from HSIL cytology specimens are overlapped. However, the scores of both intermediate and superficial 
cells showed clear separation between the negative and HSIL cytology specimens. This reinforces the observa-
tion that the differences between the negative and HSIL cytology specimens are highly significant compared to 
the differences between the two cell types. It must be noted that some of the LV scores of the HSIL intermediate 
dataset are skewed towards the scores of the negative cytology specimens (Fig. 5). This could be attributed to 
the facts that some HSIL cytology specimens can regress back to normal32,33 or some cells in the HSIL specimen 
can still be normal biochemically as well as morphologically. The predicted probability plots from the developed 
PLS-DA models provided sensitivities of 95.5%, 95.2% and 96.1% and specificities of 92.7%, 94.7%, and 93.5% 
(Table 2), respectively, for identifying the HSIL cases based on the spectral dataset obtained from intermediate 
cells (Fig. 6a), superficial cells (Fig. 6b), and mixed intermediate/superficial cells (Fig. 6c). The predicted proba-
bility plot of the mixed intermediate/superficial cells (Fig. 6c) further shows that the diagnostic efficacy of identi-
fying HSIL is not significantly affected by mixing the intermediate and superficial cell types. This result was again 
consistent with our previous study which showed clustering of stroma, basal/parabasal, and superficial/interme-
diate layers characterized by the Raman signatures of collagen, DNA bases, and glycogen, respectively31. We also 
compared the diagnostic efficiency of the PLS-DA method with PCA-LDA as this is very frequently used for can-
cer and precancer diagnosis using Raman spectroscopy. The standard PCA-LDA method provided sensitivities of 
74.9%, 72.8%, and 75.6% and specificities of 89.9%, 81.9%, and 84.5%, respectively, for HSIL diagnosis based on 
Figure 3. Difference Raman spectra ± 1 standard deviation (SD) obtained from (a) intermediate cells of 
negative cytology and high-grade squamous intraepithelial lesion (HSIL) cytology specimens and (b) superficial 
cells of negative cytology and HSIL cytology specimens. Raman spectra were acquired from morphologically 
normal appearing intermediate and superficial cells in the HSIL cytology specimens.
Type of cells
PCA-LDA PLS-DA
Sensitivity (%) Sensitivity (%) Sensitivity (%) Specificity (%)
Intermediate 74.9 89.9 95.5 92.7
Superficial 72.8 81.9 95.2 94.7
Intermediate + Superficial 75.6 84.5 96.1 93.5
Table 2. Calculated sensitivities and specificities for differentiating negative cytology and high-grade squamous 
intraepithelial lesion (HSIL) cytology using the Raman spectral dataset obtained from (i) intermediate cells, (ii) 
superficial cells and (iii) mixed intermediate and superficial cells.
www.nature.com/scientificreports/
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the dataset obtained from intermediate, superficial and mixed intermediate/superficial cells. The PLS-DA mod-
els were found to perform better than PCA-LDA models because PCA realises the dimensionality reduction by 
retaining much of the information in the spectral dataset, however, PLS reduces the dimensionality by explaining 
Figure 4. PLS components (LVs) loadings of the developed PLS-DA model for the dataset obtained from (a) 
intermediate cells, (b) superficial cells and (c) mixed intermediate and superficial cells. (latent variables (LVs), 
partial least squares discriminant analysis (PLS-DA)).
Figure 5. Scatter plot of the significant latent variables (LVs) obtained from the Raman spectral dataset of 
mixed intermediate and superficial cells of negative cytology and high-grade squamous intraepithelial lesion 
(HSIL) cytology specimens.
Figure 6. Scatter plot of the predicted probability values calculated from the Raman dataset obtained from (a) 
intermediate cells, (b) superficial cells and (c) mixed intermediate and superficial cells of negative and HSIL 
cytology specimens.
www.nature.com/scientificreports/
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as much of the variation by considering the correlated relationships between the spectral dataset and the class 
membership25. Since the intermediate and superficial cells can be mixed together without affecting the efficacy of 
HSIL diagnosis, this tedious and time consuming process of staining and revisiting the Raman measured cells for 
the identification of cell type can be eliminated in future studies. This study confirms the earlier FTIR spectros-
copy studies18,19 showing that morphologically normal cells from abnormal samples show distinct biochemical 
changes and indicate that biochemical changes are pervasive in the epithelium in the presence of a HSIL lesion. 
These findings support the concept of ‘field change’ in the epithelium at a biochemical/molecular level in cervical 
precancer. This study has further extended the earlier FTIR spectroscopy studies to demonstrate that HSIL can be 
detected irrespective of the cell type being measured i.e., intermediate cells, superficial cells or a mixed population 
of intermediate and superficial cells. Work is ongoing to extend the spectral library of negative and HSIL speci-
mens to improve the PLS-DA model in order to predict unknown specimens in a real clinical setting.
Conclusions
Raman spectra were successfully acquired from the intermediate and superficial cells of negative cytology speci-
mens and morphologically normal appearing intermediate and superficial cells of HSIL cytology specimens. The 
inter-cell type differences in the Raman spectra showed significantly less variability than the differences between 
the negative and HSIL cytology. This study demonstrates the potential of Raman spectroscopy for identifying 
HSIL at cytology from the spectra acquired from morphologically normal appearing cells and further shows that 
a mixed population of superficial and intermediate cell types can be used. It also carries an implication that many 
cells are potentially committed to a HSIL lineage, although cytologically viewed as normal. Dysplasia therefore 
can be seen as a cellular ‘bar-coding’ phenomenon and Raman spectroscopy appears to be sensitive enough to 
detect this. This study brings the translation of Raman spectroscopy to cervical cancer screening closer by elimi-
nating the difficulty of finding the rare morphologically abnormal cells on the unstained slides.
Data Availability
The datasets generated and analysed during this study are available from the corresponding author on reasonable 
request.
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